Clinical Trial

Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 24, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This open-label, single-group, pre/post-test clinical study was conducted to investigate whether ExoBDNF probiotic supplementation could improve cognitive ability. It is expected that 40 subjects aged 18 years and above will be recruited, with a target of 30 cases, to take ExoBDNF probiotics for a total of 8 weeks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-05.
Status change: Not Yet Recruiting → Recruiting 2025-11-18
Trial Details
NCT Number NCT06968299
Lead Sponsor SunWay Biotech Co., LTD.
Conditions Cognitive Functions Perceptual Disturbances, Cognitive Function Abnormal, Sleep, Psychological
Enrollment 50 participants
Start Date 2025-05-20
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-24